Apollo Hospitals Stock: HealthCo Demerger and 1,500-Bed Expansion Drive Multi-Year Growth
Strong Q3 performance and strategic restructuring push brokerages to maintain buy ratings with 20% upside as hospital margins hit 24.8% and pharmacy business nears breakeven Apollo Hospitals Enterprise is executing a transformation that goes well beyond quarterly earnings beats. India’s largest hospital chain delivered a consolidated EBITDA of Rs 9.7Continue Reading
Infosys Has a New AI Playbook
Infosys tells investors exactly how it plans to win the AI era – and analysts reckon the upside case is good Infosys held its AI Investor Day recently, and the message from management was unambiguous: it’s not another technology cycle to be managed, but a shift that the company intendsContinue Reading
Torrent Pharma Stock: A Strong Quarter
Torrent Pharma delivered a textbook quarter — revenues up 18 per cent year-on-year to Rs 33 billion, profits climbing 26 per cent to Rs 6.4 billion, and EBITDA margins nudging up 40 basis points to 32.9 per cent. In the ordinary course of business, that would have been the headline.Continue Reading
Britannia Industries Stock: Brokers See Up to 21% Upside as New CEO Bets Big on Brands
A GST-driven margin surprise and accelerating sales has brokerages agree the growth story has legs Britannia Industries is back in a sweet spot. The country’s largest biscuit maker delivered a margin performance in Q3FY26 that surprised even optimistic analysts, while a new chief executive has arrived with an ambitious agendaContinue Reading
IPCA Laboratories Sees Strong Margin Expansion; Brokers See 15-28% Upside
Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls IPCA Laboratories has emerged as a growth story in India’s pharmaceutical sector with two leading brokerages issuing buy recommendations following the company’s third-quarter performance that showcased margin expansion even as revenue growth remained modest. TheContinue Reading
Four Mainboard IPOs Worth Rs 5,700 Crore Line Up After Fractal, Aye Finance Disappoint on Debut
Four main board IPOs have lined up IPOs, but will they see enough subscription? The primary market is bracing for a busy fortnight with four mainboard initial public offerings aggregating Rs 5,700 crore set to open for subscription, even as Monday’s twin listings of Fractal Analytics and Aye Finance deliveredContinue Reading
Can Indian IT Stocks Survive The AI Era?
With Nifty IT down 15% in a month and FCF yields at crisis levels, analysts ask: Is this a Kodak moment or a generational buying opportunity? The question haunting Dalal Street’s technology corner isn’t whether AI will disrupt Indian IT services. It’s whether the disruption has already been priced inContinue Reading
This Jewellery Firm Has Grown Revenues at 50% This Quarter
A 50% revenue surge and 400% profit jump have made analysts sit up and take notice When a mid-cap jewellery stock delivers revenue growth of 50% and profit growth north of 400% in a single quarter, you’d expect analysts to be tripping over themselves. Senco Gold’s Q3FY26 results has drivenContinue Reading
Lupin’s US Generics Juggernaut Delivers Another Nice Quarter — But Can the Magic Last?
Lupin has delivered the goods this quarter. When a pharmaceutical company beats estimates across revenue, margins, and profit in a single quarter, investors tend to sit up. When it does so by margins wide enough to force analysts to revise their numbers upward, the question shifts from “is this good?”Continue Reading
This State’s Liquor Policy Overhaul Hands Two Spirit Makers a Shot at Double-Digit Gains
Uttar Pradesh is rolling out the welcome mat for alcohol manufacturers, and it could change the fortunes of two home grown brewers. When India’s largest state decides to roll out the welcome mat for alcohol manufacturers, investors would do well to pour themselves a drink and pay attention. Uttar Pradesh,Continue Reading